National Bank of Canada’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
N
National Bank of Canada's REGN Position: Q2 2026 in Review
National Bank of Canada reduced its Regeneron Pharmaceuticals (REGN) stake by 3.2% in Q2 2026, selling an estimated $2.85M and leaving 125,812 shares worth $78.5M. The position accounts for 0.06% of the portfolio, ranked #253.
National Bank of Canada first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $105M in Q4 2023. 840 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- National Bank of Canada held 125,812 shares of Regeneron Pharmaceuticals worth $78.5M as of Q2 2026.
- National Bank of Canada sold 4,194 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.85M.
- Regeneron Pharmaceuticals made up 0.06% of National Bank of Canada's portfolio in Q2 2026, its #253 holding.
- National Bank of Canada first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
- National Bank of Canada's Regeneron Pharmaceuticals position peaked at $105M in Q4 2023.
- 840 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.